- /
- Supported exchanges
- / US
- / SNSE.NASDAQ
Sensei Biotherapeutics Inc (SNSE NASDAQ) stock market data APIs
Sensei Biotherapeutics Inc Financial Data Overview
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Sensei Biotherapeutics Inc data using free add-ons & libraries
Get Sensei Biotherapeutics Inc Fundamental Data
Sensei Biotherapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -22 149 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Sensei Biotherapeutics Inc Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2025-12-31
- EPS/Forecast: -4.81
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sensei Biotherapeutics Inc News
New
Sensei Biotherapeutics (SNSE): Best Performing NASDAQ Stocks According to Wall Street Analysts
Sensei Biotherapeutics Inc. (NASDAQ:SNSE) is one of the best performing NASDAQ stocks according to Wall Street analysts. On March 30, Sensei Biotherapeutics shifted its focus following the acquisition...
Most and least shorted small-to-mid-cap stocks
[short sale sign] Gunter_Nezhoda Short interest across small- to mid-cap stocks highlights extreme positioning at both ends, with highly speculative micro-cap names drawing heavy bearish bets, while ...
Sensei Biotherapeutics GAAP EPS of -$16.72
* Sensei Biotherapeutics press release [https://seekingalpha.com/pr/20454976-sensei-biotherapeutics-reports-full-year-2025-financial-results-and-provides-corporate-update] (SNSE [https://seekingalph...
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
VANCOUVER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary — Big money is moving back into biotech. Institutional investors have been writing some of the la...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.